CLINICAL_TRIALS
trial_result
· 2025-05-13
Clinical Trial Update: Blinatumomab Bridging Therapy for BALL [Phase 2]
Summary
Phase 2 trial evaluating blinatumomab as bridging therapy for B-cell acute lymphoblastic leukemia was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Michael Burke | Conditions: B-cell Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2025-05-13